Pharmacovigilance Market Size, Share & Industry Analysis, By Type (Service and Software), By Deployment (In-house and Outsource), By End-User (Contract Research Organizations (CROs), Pharmaceutical & Biotechnfology Companies, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 13.8% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Type

• Service
• Software

By Deployment 

• In-house
•  Outsource

By End User

• Contract Research Organizations (CROs)
• Pharmaceutical & Biotechnology Companies
• Others

By Region

• North America (By Type, Deployment, End-User, and Country)
  • U.S. (By Type)
  • Canada (By Type)
• Europe (By Type, Deployment, End-User, and Country/Sub-Region)
  • Germany (By Type)
  • U.K. (By Type)
  • France (By Type)
  • Italy (By Type)
  • Spain (By Type)
  • Rest of Europe (By Type)
• Asia Pacific (By Type, Deployment, End-User, and Country/Sub-Region)
  • China (By Type)
  • Japan (By Type)
  • India (By Type)
  • Australia (By Type)
  • Southeast Asia (By Type)
  • Rest of Asia Pacific (By Type)
• Latin America (By Type, Deployment, End-User, and Country/Sub-Region)
  • Brazil (By Type)
  • Mexico (By Type)
  • Rest of Latin America (By Type)
• Middle East & Africa (By Type, Deployment, End-User, and Country/Sub-Region)
  • GCC (By Type)
  • South Africa (By Type)Rest of the Middle East & Africa (By Type)